SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011282
Filing Date
2021-08-11
Accepted
2021-08-11 16:06:34
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mist-20210630x10q.htm   iXBRL 10-Q 1308100
2 EX-4.1 mist-20210630xex4d1.htm EX-4.1 325509
3 EX-10.1 mist-20210630xex10d1.htm EX-10.1 429038
4 EX-31.1 mist-20210630xex31d1.htm EX-31.1 12314
5 EX-31.2 mist-20210630xex31d2.htm EX-31.2 12465
6 EX-32.1 mist-20210630xex32d1.htm EX-32.1 9433
  Complete submission text file 0001558370-21-011282.txt   5596157

Data Files

Seq Description Document Type Size
7 EX-101.SCH mist-20210630.xsd EX-101.SCH 30142
8 EX-101.CAL mist-20210630_cal.xml EX-101.CAL 27377
9 EX-101.DEF mist-20210630_def.xml EX-101.DEF 96815
10 EX-101.LAB mist-20210630_lab.xml EX-101.LAB 281868
11 EX-101.PRE mist-20210630_pre.xml EX-101.PRE 206210
12 EXTRACTED XBRL INSTANCE DOCUMENT mist-20210630x10q_htm.xml XML 876319
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38899 | Film No.: 211163445
SIC: 2834 Pharmaceutical Preparations